Literature DB >> 31890456

A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet.

Matteo Pasca1, Antonella Picchioni1, Salvatore Mazzeo1, Federica Terenzi1, Elio Prestipino1, Roberto Fratangelo1, Anna Maria Repice1,2, Giovanna Carlucci1,2, Luca Massacesi1,2, Alessandro Barilaro1,2.   

Abstract

We reported the case of a John Cunningham virus (JCV) and human herpesvirus 6 (HHV-6) mediated progressive multifocal leukoencephalopathy (PML) after human stem cell transplant, reactivated 6 months later in absence of immunosuppressive therapy, successfully treated with anti-5HT2A receptors agents and antiviral therapy. Few cases of JCV and HHV-6 coinfection associated PML are described in literature and the role of HHV-6 in the pathogenesis and prognosis of PML is not completely clear. Our case suggests that, in a possible PML, the research of HHV-6 and JCV should be always performed on cerebrospinal fluid (CSF) and on blood samples and in case of detection of HHV-6 DNA a chromosomally integrated human herpesvirus 6(ciHHV-6) should be excluded. Furthermore we recommend to start an appropriate therapy with antiviral and anti-5HT2A receptors agents in case of possible PML due to JCV and HHV-6 coinfection. 2019, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  CNS infection; Neurovirology; human herpesvirus 6

Year:  2019        PMID: 31890456      PMCID: PMC6929596          DOI: 10.5582/irdr.2019.01107

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  15 in total

Review 1.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 2.  The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era: Prevention and Management.

Authors:  Eamonn S Molloy; Cassandra M Calabrese; Leonard H Calabrese
Journal:  Rheum Dis Clin North Am       Date:  2017-02       Impact factor: 2.670

3.  Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation: Case report and review of the literature.

Authors:  Cai Yuan; Candace Deberardinis; Rushang Patel; Seema M Shroff; Steven A Messina; Steven Goldstein; Shahram Mori
Journal:  Transpl Infect Dis       Date:  2018-03-31       Impact factor: 2.228

4.  Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphoma.

Authors:  M Daibata; N Hatakeyama; M Kamioka; Y Nemoto; M Hiroi; I Miyoshi; H Taguchi
Journal:  Am J Hematol       Date:  2001-07       Impact factor: 10.047

5.  Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders.

Authors:  C Quereda; I Corral; F Laguna; M E Valencia; A Tenorio; J E Echeverria; E Navas; P Martín-Dávila; A Moreno; V Moreno; J M Gonzalez-Lahoz; J R Arribas; A Guerrero
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

6.  Incidence of progressive multifocal leukoencephalopathy in patients without HIV.

Authors:  K L Amend; B Turnbull; N Foskett; P Napalkov; T Kurth; J Seeger
Journal:  Neurology       Date:  2010-10-12       Impact factor: 9.910

7.  Human herpesvirus 6-meningoencephalitis in an HIV patient with progressive multifocal leukoencephalopathy.

Authors:  M Ito; J V Baker; D J Mock; A D Goodman; B M Blumberg; D A Shrier; J M Powers
Journal:  Acta Neuropathol       Date:  2000-09       Impact factor: 17.088

8.  Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy.

Authors:  D J Mock; J M Powers; A D Goodman; S R Blumenthal; N Ergin; J V Baker; D H Mattson; J G Assouline; E J Bergey; B Chen; L G Epstein; B M Blumberg
Journal:  J Neurovirol       Date:  1999-08       Impact factor: 2.643

Review 9.  Chromosomally integrated human herpesvirus 6: questions and answers.

Authors:  Philip E Pellett; Dharam V Ablashi; Peter F Ambros; Henri Agut; Mary T Caserta; Vincent Descamps; Louis Flamand; Agnès Gautheret-Dejean; Caroline B Hall; Rammurti T Kamble; Uwe Kuehl; Dirk Lassner; Irmeli Lautenschlager; Kristin S Loomis; Mario Luppi; Paolo Lusso; Peter G Medveczky; Jose G Montoya; Yasuko Mori; Masao Ogata; Joshua C Pritchett; Sylvie Rogez; Edward Seto; Katherine N Ward; Tetsushi Yoshikawa; Raymund R Razonable
Journal:  Rev Med Virol       Date:  2011-11-04       Impact factor: 6.989

10.  Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients.

Authors:  Karen Yao; Susan Gagnon; Nahid Akhyani; Elizabeth Williams; Julie Fotheringham; Elliot Frohman; Olaf Stuve; Nancy Monson; Michael K Racke; Steven Jacobson
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.